Evidence map›Paper›PMID 35286299›Full record

ArticlePLoS genetics2022

Identification of an evolutionarily conserved domain in Neurod1 favouring enteroendocrine versus goblet cell fate.

Anne Sophie Reuter, David Stern, Alice Bernard, Chiara Goossens, Arnaud Lavergne, Lydie Flasse, Virginie Von Berg, Isabelle Manfroid, Bernard Peers, Marianne L Voz

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Anne Sophie ReuterLaboratory of Zebrafish Development and Disease Models (ZDDM), GIGA, University of Liège, Liège, Belgium.
David SternLaboratory of Zebrafish Development and Disease Models (ZDDM), GIGA, University of Liège, Liège, Belgium.ORCID 0000-0001-5641-6636
Alice BernardLaboratory of Zebrafish Development and Disease Models (ZDDM), GIGA, University of Liège, Liège, Belgium.
Chiara GoossensLaboratory of Zebrafish Development and Disease Models (ZDDM), GIGA, University of Liège, Liège, Belgium.ORCID 0000-0002-8214-6198
Arnaud LavergneLaboratory of Zebrafish Development and Disease Models (ZDDM), GIGA, University of Liège, Liège, Belgium.ORCID 0000-0003-4817-3202
Lydie FlasseLaboratory of Zebrafish Development and Disease Models (ZDDM), GIGA, University of Liège, Liège, Belgium.
Virginie Von BergLaboratory of Zebrafish Development and Disease Models (ZDDM), GIGA, University of Liège, Liège, Belgium.
Isabelle ManfroidLaboratory of Zebrafish Development and Disease Models (ZDDM), GIGA, University of Liège, Liège, Belgium.ORCID 0000-0003-3445-3764
Bernard PeersLaboratory of Zebrafish Development and Disease Models (ZDDM), GIGA, University of Liège, Liège, Belgium.ORCID 0000-0003-0498-6180
Marianne L VozLaboratory of Zebrafish Development and Disease Models (ZDDM), GIGA, University of Liège, Liège, Belgium.ORCID 0000-0002-3620-6962
University of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ARP/ASCL transcription factors are key determinants of cell fate specification in a wide variety of tissues, coordinating the acquisition of generic cell fates and of specific subtype identities. How these factors, recognizing highly similar DNA motifs, display specific activities, is not yet fully understood. To address this issue, we overexpressed different ARP/ASCL factors in zebrafish ascl1a-/- mutant embryos to determine which ones are able to rescue the intestinal secretory lineage. We found that Ascl1a/b, Atoh1a/b and Neurod1 factors are all able to trigger the first step of the secretory regulatory cascade but distinct secretory cells are induced by these factors. Indeed, Neurod1 rescues the enteroendocrine lineage while Ascl1a/b and Atoh1a/b rescue the goblet cells. Gain-of-function experiments with Ascl1a/Neurod1 chimeric proteins revealed that the functional divergence is encoded by a 19-aa ultra-conserved element (UCE), present in all Neurod members but absent in the other ARP/ASCL proteins. Importantly, inserting the UCE into the Ascl1a protein reverses the rescuing capacity of this Ascl1a chimeric protein that cannot rescue the goblet cells anymore but can efficiently rescue the enteroendocrine cells. This novel domain acts indeed as a goblet cell fate repressor that inhibits gfi1aa expression, known to be important for goblet cell differentiation. Deleting the UCE domain of the endogenous Neurod1 protein leads to an increase in the number of goblet cells concomitant with a reduction of the enteroendocrine cells, phenotype also observed in the neurod1 null mutant. This highlights the crucial function of the UCE domain for NeuroD1 activity in the intestine. As Gfi1 acts as a binary cell fate switch in several tissues where Neurod1 is also expressed, we can envision a similar role of the UCE in other tissues, allowing Neurod1 to repress Gfi1 to influence the balance between cell fates.

Indexed as

Goblet CellsZebrafishAnimalsCell DifferentiationTranscription FactorsZebrafish ProteinsTranscription FactorsZebrafish Proteins

Identifiers

PMID35286299
PMCPMC8959185
OpenAlexW4220984935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.